We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准Fasenra用于治疗嗜酸性粒细胞增多综合征。Benralizumab相比同类药物有何优势，以及为何这是阿斯利康的战略转变。了解其前景。
